Cellmade

Year of investment: 2010

CellMade develops and commercializes cell biology products and services: human-origin primary cells, co-culture models, customized cell isolation and characterization. CellMade also invests in its own R&D program using its CellInsight platform for identification of targets and biomarkers related to inflammatory pathologies. The company has facilities in Marseille (France) and at the Chemelot Campus.

Chemtrix

Year of investment: 2008

Chemtrix BV supplies complete and customized microreactor systems for R&D and commercial manufacturing. Chemtrix’ microreactors enhance process efficiency, energy efficiency and safety of chemical synthesis in the fine chemical and pharmaceutical industries.

Basic Pharma

Year of investment: 2005

Basic Pharma is an advanced, independent pharmaceutical company primarily engaged in developing, licensing, manufacturing and commercialisation of pharmaceutical and biopharmaceutical products. Basic Pharma delivers a full service package to the Pharmaceutical, Biotech and Medical Device industry.

Fortimedix

Year of investment: 2004

In 2009 the company was part of a transaction involving an MBI and which provided a partial exit for shareholders.
The assets were transferred to Fortimedix Holding BV.